Analyst downgrades: HSY, COGN, RMD and ARTE
Posted Nov 14th 2007 11:20AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Target Corp. (TGT), Hershey Co (HSY), Rio Tinto plc ADS (RIO)
.gif)
MOST NOTEWORTHY: Hershey Foods, Cognos, Resmed and Artes Medical were today's noteworthy downgrades:
- Hershey (NYSE: HSY) was downgraded to Underperform from Peer Perform at Bear Stearns. Bear believes the new CEO will be under intense pressure to improve operating performance, which will likely lead to higher R&D and marketing spending.
- Cognos (NASDAQ: COGN) was downgraded to Equal Weight from Overweight at Morgan Stanley following the acquisition by IBM (NYSE: IBM).
- ABN Amro lowered its rating on Resmed (NYSE: RMD) to Hold from Buy on valuation following the recent rally.
- Cowen downgraded Artes Medical (NASDAQ: ARTE) to Neutral from Buy following the company's disappointing Q3 report.
OTHER DOWNGRADES:
Tags: analyst, arte, artes medical, ArtesMedical, cogn, cognos, downgrade, gatehouse, ghs, hershey, hsy, ibm, news, newstar, rio tinto, RioTinto, rtp, target, tgt
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
5 Signs You're Getting Robbed at the Hospital
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
